Drug profile · INN
potassium citrate
SIBNAYAL
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
potassium citrate (SIBNAYAL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →Frequently asked questions
What is potassium citrate?
potassium citrate (SIBNAYAL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for potassium citrate?
SIBNAYAL is a marketed brand name for potassium citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of potassium citrate?
potassium citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.